Vanitha Ramakrishnan
Impact in
- Physiology top 0.5%
- Adenosine and Purinergic Signaling
- Hematology top 1%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
Papers in
- Hematology 11
- Platelet Disorders and Treatments 6
- Blood Coagulation and Thrombosis Mechanisms 4
- Genetics 9
- Chronic Lymphocytic Leukemia Research 7
- Co-authors
- Laura J. England (1 shared paper)Pamela B. Conley (1 shared paper)David J. Julius (1 shared paper)Ruey‐Bing Yang (1 shared paper)Paquita Nurden (1 shared paper)Georgia Li (1 shared paper)Gunther Hollopeter (1 shared paper)Alan T. Nurden (1 shared paper)
- Journals
- Clinical Cancer Research (4 papers)Blood (3 papers)Molecular Cancer Therapeutics (3 papers)Growth Factors (2 papers)HemaSphere (2 papers)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Vanitha Ramakrishnan
40 papers receiving 3.6k citations
Vanitha Ramakrishnan's Hit Papers
Peers
Comparison fields: 5 of 89
- Physiology 442
- Hematology 977
- Immunology and Allergy 196
- Genetics 199
- Cardiology and Cardiovascular Medicine 402
Countries citing papers authored by Vanitha Ramakrishnan
This map shows the geographic impact of Vanitha Ramakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanitha Ramakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanitha Ramakrishnan more than expected).
Fields of papers citing papers by Vanitha Ramakrishnan
This network shows the impact of papers produced by Vanitha Ramakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanitha Ramakrishnan. The network helps show where Vanitha Ramakrishnan may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanitha Ramakrishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of the platelet ADP receptor targeted by antithrombotic drugs Hit paper breakdown → | 2001 | 1206 |
| 2 | 2008 | 319 | |
| 3 | 1996 | 315 | |
| 4 | 2014 | 179 | |
| 5 | 2001 | 138 | |
| 6 | 2014 | 122 | |
| 7 | Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. | 2006 | 107 |
| 8 | 2003 | 97 | |
| 9 | 2020 | 95 | |
| 10 | 1999 | 92 | |
| 11 | 2013 | 77 | |
| 12 | 2004 | 73 | |
| 13 | 2007 | 73 | |
| 14 | 2013 | 71 | |
| 15 | 1999 | 70 | |
| 16 | 2001 | 66 | |
| 17 | 2010 | 66 | |
| 18 | 2014 | 66 | |
| 19 | 2010 | 65 | |
| 20 | E-selectin up-regulation allows for targeted drug delivery in prostate cancer. | 2003 | 59 |
About Vanitha Ramakrishnan
Vanitha Ramakrishnan is a scholar working on Hematology, Genetics, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 40 papers that have together received 3.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Platelet Disorders and Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Cell Adhesion Molecules Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Prostate Cancer Treatment and Research (3 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Physiology (442 citations), Hematology (977 citations), Immunology and Allergy (196 citations), Genetics (199 citations) and Cardiology and Cardiovascular Medicine (402 citations). Vanitha Ramakrishnan has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Laura J. England, Pamela B. Conley, David J. Julius, Ruey‐Bing Yang, Paquita Nurden, Georgia Li, Gunther Hollopeter, Alan T. Nurden, Hans‐Michael Jantzen and Johan Sundelin. Their work appears in journals such as Clinical Cancer Research, Blood, Molecular Cancer Therapeutics, Growth Factors and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.